 Studies to supply these proofs rest primarily on determining if TP receptor antagonists are clinically useful.However, these studies face issues that drugs which indirectly target TP (e.g.Nonsteroidal anti-inflammatory drugs that block TXA2 production) or which circumvent TP (e.g.